Clinical trial / 2014
Prolonged fasting reduced IGF-1 and PKA signaling, promoting hematopoietic stem cell regeneration and alleviating chemotherapy-induced immunosuppression.
Researchers investigated the effects of prolonged fasting on hematopoietic stem cell protection and regeneration in mice, supplemented by preliminary data from fasting patients. Prolonged fasting lowered circulating IGF-1 levels and PKA activity, promoting stress resistance, self-renewal, and lineage-balanced regeneration in long-term hematopoietic stem cells. Multiple fasting cycles abated chemotherapy-induced immunosuppression and mortality and reversed age-dependent myeloid bias in mice, aligning with preliminary findings indicating lymphocyte protection against chemotoxicity in fasting patients. The proregenerative effects were reproduced by IGF-1 or PKA deficiencies and blunted by exogenous IGF-1.
- Study type
- Preclinical animal model with preliminary human clinical data
- Who was studied
- Mice and fasting human patients undergoing chemotherapy (exact sample sizes not stated)
- What was measured
- Circulating IGF-1, PKA activity, LT-HSC regeneration, chemotherapy toxicity, immunosuppression, and lymphocyte protection
THE PAPER
Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression.
Cheng CW, Adams GB, Perin L, Wei M, Zhou X, Lam BS, Da Sacco S, Mirisola M, Quinn DI, Dorff TB, Kopchick JJ, Longo VD. Cell Stem Cell, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.